Trials / Completed
CompletedNCT02045524
A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- JDP Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to investigate the pharmacokinetics (PK) of JDP-205 injection at 10 mg dose administered by intramuscular injection using various injection techniques in healthy male and female volunteers after a single dose administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Deep muscle injection | |
| OTHER | Sub-Q Injection |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2014-01-27
- Last updated
- 2024-03-06
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02045524. Inclusion in this directory is not an endorsement.